Aquestive Therapeutics Inc (AQST)
SG&A Expenses
$73.11M
TTM · Period ending: · USD
AQST SG&A Expenses
Latest reported$73.11Mperiod ending
Latest reported$73.11Mperiod ending
AQST TTM SG&A Expenses ($25.08M → $73.11M)
TTM SG&A Expenses
High-resolution chart · PNG
AQST sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 73,112,000 | |
| 71,754,000 | |
| 79,849,000 | |
| 63,036,000 | |
| 59,912,000 | |
| 58,563,000 | |
| 50,180,000 | |
| 43,721,000 | |
| 38,980,000 | |
| 34,984,000 | |
| 31,750,000 | |
| 34,012,000 | |
| 39,086,000 | |
| 47,313,000 | |
| 52,879,000 | |
| 56,048,000 | |
| 55,718,000 | |
| 53,265,000 | |
| 53,475,000 | |
| 54,076,000 | |
| 53,750,000 | |
| 54,510,000 | |
| 55,892,000 | |
| 56,784,000 | |
| 58,695,000 | |
| 61,047,000 | |
| 64,342,000 | |
| 66,571,000 | |
| 65,202,000 | |
| 82,603,000 | |
| 72,264,000 | |
| 61,126,000 | |
| 54,942,000 | |
| 26,518,000 | |
| 25,077,000 |